Keywords: Amgen, Fourth quarter and full year 2011 finaincial results

Lower anemia drug sales hit Amgen profit

Article | 30 January 2012

Global independent biotech leader Amgen (Nasdaq: AMGN) reported fourth-quarter 2011 results with 3% growth in revenues to $3.97 billion, Adjusted net income decreased 6% ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Amgen

Go to company listing